Corey Seager and Josh Jung are candidates for offseason surgery, Rangers announce

What happened

The Texas Rangers have two of their most important position players facing the possibility of offseason surgery. MLB.com reported that shortstop Corey Seager is a candidate for elbow surgery and third baseman Josh Jung is a candidate for hand surgery, with both procedures potentially affecting their availability at the start of next season.

Neither procedure has been described as scheduled or certain. The framing — candidates for surgery — preserves meaningful uncertainty about whether either player ultimately goes under the knife, and the club has not announced a timetable for either.

Why it matters

The Rangers finished 2026 at 80-82, eliminated from both the AL West division race and the Wild Card race, and the offseason that follows is already carrying significant organizational weight. Rangers GM Chris Young publicly acknowledged team shortcomings and pledged to address the club's issues after missing the 2026 postseason, per earlier reporting. Walking into that rebuild window with two cornerstone players in surgical limbo is not the ideal starting position.

Seager and Jung are not peripheral contributors. Seager is the franchise shortstop, the kind of player whose presence or absence reshapes lineup construction, payroll flexibility, and the entire calculus of what moves make sense around him. Jung occupies the hot corner and represents one of the organization's most significant homegrown investments. When both of those players are simultaneously flagged as surgical candidates, the front office's offseason planning essentially forks into multiple contingency trees before a single transaction has been made.

The timing also matters in a practical sense. Offseason surgeries carry recovery windows that can bleed into spring training and, in more involved cases, into the regular season itself. The club has not provided a recovery estimate for either player, so the degree of risk to their opening-day availability remains genuinely open.

Is Seager's availability for opening day in question?

That is precisely what is unresolved. MLB.com's report flags Seager as a candidate for elbow surgery without specifying the procedure or its expected recovery timeline. What is known is that Seager missed 60 games for the second consecutive season in 2026, per prior Posterior Wire reporting, a durability pattern that was already drawing attention before this latest development. Two straight seasons of 60-game absences, now potentially followed by an elbow procedure, makes the question of his availability a legitimate and open one — not a settled answer in either direction.

Jung's situation carries similar uncertainty. A hand surgery for a third baseman — a position that demands grip strength, bat control, and the ability to absorb hard-thrown balls in the dirt — is not a trivial matter, and the club has offered no specifics about what the procedure would involve or how long recovery might take.

The numbers

Texas finished the 2026 season at 80-82 (.494), sitting 2nd in the AL West and 1 game back in the division. Their Wild Card standing placed them 4th, 4.0 games relative to the cut line — close enough to have been interesting at some point, not close enough to matter in the end. The club enters the offseason on a one-game losing streak, having been eliminated from both postseason paths.

That 80-82 record is the backdrop against which every offseason decision gets made. It is a team that was not far enough away to rebuild from scratch and not close enough to simply retool at the margins. The surgical uncertainty around Seager and Jung does not simplify that math.

Where the club stands

The Rangers close the books on 2026 at 80-82, second in the AL West, with both the division title and Wild Card berth out of reach. GM Chris Young has already gone on record acknowledging the team's shortcomings and committing to fixes, per multiple reports over the past several days. The offseason agenda was already substantial before MLB.com's report on Seager and Jung; it is now more complicated.

The practical question for the front office is how to plan around two players whose availability for the start of next season is genuinely uncertain. Roster construction, free-agent targeting, trade conversations — all of it is harder to execute when the status of your shortstop and third baseman is unresolved. The club will need answers on both surgical decisions, and then on recovery timelines, before it can draw a clear picture of what the opening-day roster actually looks like.

What we don't know yet

Neither surgery has been announced as scheduled. The specific nature of Seager's elbow issue and Jung's hand issue have not been detailed in the reporting. Recovery timelines for either player have not been provided. Whether either procedure, if it happens, would affect their availability for spring training, opening day, or some later point in the season remains unknown.

The "candidate for surgery" designation is doing real work here. It signals that surgery is on the table and being discussed, not that it has been decided. There may be non-surgical options still under consideration for one or both players. Until the club announces a decision, the honest answer to most follow-up questions is: not yet known.

What to watch

The first thing to watch is whether either player's surgical status moves from "candidate" to something more definitive. An announcement from the club — in either direction — would clarify the offseason planning picture considerably.

Beyond that, watch how the Rangers approach the positions themselves. If one or both players are expected to miss time at the start of next season, the front office's moves at shortstop and third base this winter will carry a different kind of urgency. GM Chris Young has already signaled a willingness to make changes; the Seager and Jung situations will shape where those changes are most needed.

The durability question around Seager, in particular, has now extended across multiple seasons and is no longer a one-year anomaly. Two consecutive 60-game absences, and now a potential elbow procedure, make his long-term health one of the defining storylines of the Rangers' offseason — regardless of how the surgical decision ultimately lands.